I-Sens Inc. (099190)
KRX SM KRX SM Primary Summary
I-Sens Inc. (099190) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has I-Sens Inc. ever had a stock split?
I-Sens Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | - CEO | KRX SM Exchange | KR7099190001 ISIN |
| South Korea Country | - Employees | 29 Dec 2025 Last Dividend | 14 Mar 2023 Last Split | - IPO Date |
Overview
I-Sens Inc. is a distinguished entity within the medical technology landscape, primarily celebrated for its innovations in enhancing diabetic care through the development and manufacture of advanced diagnostic equipment. The organization champions the evolution of blood glucose monitoring systems that are essential for both personal and clinical applications, ensuring the provision of accurate and timely glucose level assessments to support effective diabetes management. With a commitment to precision, reliability, and user accessibility, I-Sens's flagship products stand at the forefront of empowering patients and healthcare professionals with superior monitoring capabilities. Furthermore, the company's ambition transcends diabetes care, venturing into wider realms of medical diagnostics to broaden its impact on global health standards. Central to its success is a robust research and development foundation, which fuels I-Sens's quest for pioneering breakthroughs in healthcare technology. Operating across numerous international markets, I-Sens Inc. is an influential force driving the advancements and accessibility of vital diagnostic tools, significantly shaping the contours of contemporary healthcare practices.
Products and Services
- Blood Glucose Monitoring Systems
I-Sens Inc.'s cornerstone lies in its range of blood glucose monitoring systems tailored for both individual and professional use. These systems are designed to offer not only precision and accuracy in readings but also simplicity in operation, making diabetes management more effective and less intrusive for users. The devices cater to a growing need for real-time data that can aid in better diabetic care and day-to-day lifestyle adjustments.
- Research and Development in Medical Diagnostics
Beyond its primary focus on diabetes care, I-Sens is deeply invested in the expansive field of medical diagnostics. This commitment is evident in its continuous pursuit of innovation and excellence within the healthcare tech space. By leveraging its strong R&D capabilities, I-Sens aims to unveil new diagnostic solutions that address a broad spectrum of healthcare needs, enhancing overall patient care and contributing to the global advancement of medical technology.
